Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Regulation FD disclosure
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. CT ORDER Other Confidential Order
  8. 10-Q/A Report 10-Q/A
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. DEF 14A Proxy Proxy Statement
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 8-K Event Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. UPLOAD Other SEC-generated Letter
  20. 8-K Event Other events

Page 47 of 68 · 1,358 filings